End of phase I results of ZUMA-3, a phase 1/2 study of KTE-X19, anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL).

被引：0
作者：
Shah, Bijal D.
Bishop, Michael Russell
Oluwole, Olalekan O.
Logan, Aaron
Baer, Maria R.
Donnellan, William Bruce
Carr-O'Dwyer, Kristen Marie
Holmes, Houston
Arellano, Martha Lucia
Ghobadi, Armin
Pagel, John M.
Lin, Yi
Cassaday, Ryan Daniel
Park, Jae Hong
Mardiros, Armen
Shen, Tong
Goyal, Lovely
Vezan, Remus
Jain, Rajul K.
Wierda, William G.
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[3] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[4] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA
[5] Univ Maryland, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA
[6] Sarah Cannon Res Inst, Nashville, TN USA
[7] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[8] Texas Oncol, Baylor Charles A Sammons Canc Ctr, Dallas, TX USA
[9] Winship Canc Inst, Atlanta, GA USA
[10] Washington Univ, Sch Med, St Louis, MO USA
[11] Siteman Canc Ctr, St Louis, MO USA
[12] Swedish Canc Inst, Seattle, WA USA
[13] Mayo Clin, Rochester, MN USA
[14] Univ Washington, Sch Med, Seattle, WA USA
[15] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[16] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[17] Kite, Santa Monica, CA USA
[18] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7006
引用
收藏
页数：2
相关论文
共 50 条
[41]   Kinetics of immune reconstitution after anti-CD19 chimeric antigen receptor T cell therapy in relapsed or refractory acute lymphoblastic leukemia patients [J].
Wang, Ying ;
Li, Hujun ;
Song, Xuguang ;
Qi, Kunming ;
Cheng, Hai ;
Cao, Jiang ;
Shi, Ming ;
Yan, Zhiling ;
Jing, Guangjun ;
Pan, Bin ;
Sang, Wei ;
Wang, Xiangmin ;
Zhao, Kai ;
Chen, Chong ;
Chen, Wei ;
Zheng, Junnian ;
Li, Zhenyu ;
Xu, Kailin .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (02) :250-258
[42]   Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia [J].
Runxia Gu ;
Fang Liu ;
Dehui Zou ;
Yingxi Xu ;
Yang Lu ;
Bingcheng Liu ;
Wei Liu ;
Xiaojuan Chen ;
Kaiqi Liu ;
Ye Guo ;
Xiaoyuan Gong ;
Rui Lv ;
Xia Chen ;
Chunlin Zhou ;
Mengjun Zhong ;
Huijun Wang ;
Hui Wei ;
Yingchang Mi ;
Lugui Qiu ;
Lulu Lv ;
Min Wang ;
Ying Wang ;
Xiaofan Zhu ;
Jianxiang Wang .
Journal of Hematology & Oncology, 13
[43]   ZUMA-4 PHASE 1 LONG-TERM RESULTS: KTE-X19 CAR T-CELL THERAPY IN CHILDREN/ADOLESCENTS WITH R/R B-ALL [J].
Wayne, Alan ;
Van Huynh ;
Hijiya, Nobuko ;
Rouce, Rayne ;
Brown, Patrick ;
Krueger, Joerg ;
Kitko, Carrie ;
Dela Ziga, Edward ;
Hermiston, Michelle ;
Richards, Michael ;
Baruchel, Andre ;
Benoun, Joe ;
Zhou, Lang ;
Goyal, Lovely ;
Vezan, Remus ;
Jain, Rajul ;
Masouleh, Behzad Kharabi ;
Lee, Daniel .
PEDIATRIC BLOOD & CANCER, 2021, 68 :S102-S103
[44]   ZUMA-2: A phase 2 multi-center study evaluating the efficacy of KTE-C19 (Anti-CD19 CAR T cells) in patients with relapsed/refractory Mantle cell lymphoma (R/R MCL) [J].
Wang, M. ;
Locke, F. L. ;
Siddiqi, T. ;
Castro, J. ;
Shah, B. ;
Lee, H. ;
Budde, L. E. ;
Choi, M. ;
Anasetti, C. ;
Champlin, R. ;
Forman, S. ;
Kipps, T. ;
Bot, A. ;
Rossi, J. M. ;
Navale, L. ;
Jiang, Y. ;
Aycock, J. ;
Elias, M. ;
Wiezorek, J. ;
Go, W. Y. .
ANNALS OF ONCOLOGY, 2016, 27
[45]   Cost-Effectiveness of KTE-X19 for Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) in the United States [J].
Shah, Bijal ;
Smith, Nathaniel ;
Raad, Angie ;
Feng, Chaoling ;
Castaigne, Gab ;
Masouleh, Behzad Kharabi ;
Malone, Daniel ;
Bishop, Michael .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 :S272-S273
[46]   Modeling Retreatment of Acute Lymphoblastic Leukemia with Anti-CD19 Chimeric Antigen Receptor T Cell Therapy [J].
Yang, Yinmeng ;
Kohler, Mark Eric ;
Fry, Terry J. .
BLOOD, 2016, 128 (22)
[47]   Product characteristics and pharmacological profile of KTE-X19 in patients (pts) with relapsed/refractory (R/R) mantle cell lymphoma (MCL) in the phase II registrational ZUMA-2 trial. [J].
Wang, Michael ;
Rossi, John M. ;
Munoz, Javier ;
Goy, Andre ;
Locke, Frederick Lundry ;
Reagan, Patrick Michael ;
Jacobson, Caron A. ;
Hill, Brian T. ;
Holmes, Houston ;
Jaglowski, Samantha Mary ;
Peng, Weimin ;
Zheng, Lianqing ;
Fang, Xiang ;
Xue, Allen ;
Rao, Arati, V ;
Bot, Adrian .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[48]   KITE-363: A phase 1 study of an autologous anti-CD19/CD20 chimeric antigen receptor (CAR) T-cell therapy in patients with relapsed/refractory (R/R) B-cell lymphoma (BCL). [J].
Nastoupil, Loretta J. ;
Dahiya, Saurabh ;
Miklos, David Bernard ;
Reagan, Patrick Michael ;
Ulrickson, Matthew ;
Jung, A. Scott ;
Kloos, Ioana ;
Dong, Jinghui ;
Chou, Justin ;
Murakami, Jodi ;
Rodriguez, Katherine ;
Nahas, Myrna .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[49]   ZUMA-4: A Phase 1/2 Multicenter Study of KTE-X19 in Pediatric and Adolescent Patients With Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma [J].
Wayne, Alan S. ;
Michel, Gerard ;
Lee, Daniel W. ;
Baruchel, Andre ;
Chaudhury, Sonali ;
Brown, Patrick A. ;
Hermiston, Michelle ;
Krueger, Joerg ;
Shen, Tong ;
Tailford, Kristy ;
Masouleh, Behzad Kharabi .
BLOOD, 2020, 136
[50]   ZUMA-8: A phase 1/2 multicenter study evaluating KTE-X19 in patients (pts) with relapsed/refractory (RR) chronic lymph ocytic leukemia (CLL). [J].
Flinn, Ian ;
Marris, Michael ;
Wierda, William G. ;
Coutre, Steven ;
Pagel, John M. ;
Byrd, John C. ;
Goyal, Lovely ;
Goodman, Krista ;
Zheng, Yan ;
Milletti, Francesca ;
Murugappan, Swaminathan ;
Brown, Jennifer R. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345